Teva Pharmaceutical Industries Limited is believed to be in preliminary discussions to buy Handok Pharmaceuticals Co., Ltd., according to reports in JoongAng Dail. Young-Jin Kim, Chief Executive Officer and Chairman of Handok, holds 46.8% of Hando and IMM Private Equity owns 30% of Handok.